Apps promote use of organ transplant medication

Tyrell have developed informational and promotional apps for global pharmaceutical company Astellas Pharma.

We have been building apps for Astellas to aid in promoting Advagraf, a medication used to reduce the rates of organ rejection following transplant.

We’ve recently completed work on a range of apps with varying functionality; sharing medication documentation and reports and studies on the efficacy of the drug, as well as collecting data from practitioners on the adverse events they record after transplants and general medical enquiries. We have also worked with local firm Equinox Design to provide the tech platform for an interactive display to be included in Astellas Pharma’s stand at various medical exhibitions, including the International Liver Transplantation Society in Prague later this month.

The ILTS 2017 exhibition will be running from the afternoon of Wednesday 24th May until Friday 26th May on the second level of the Prague Congress Centre.